Showing results (2501-2510 of 2,955) with videos related to
Sort By:
Pageof 296
Cancer Investigation|June 28, 2008
Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanomaAgop Y Bedikian, Marcella M Johnson, Carla L Warneke, et al.Cancer Investigation|June 24, 2008
The emperor's new clothes or the current practice of clinical trials for multiple myeloma in the USAOscar BallesterCancer Investigation|June 24, 2008
Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patientsTao Ren, Zhen-Ke Wen, Zhong-Min Liu, et al.Cancer Investigation|June 24, 2008
The expression of Bcl-XL, Bcl-XS and p27Kip1 in topotecan-induced apoptosis in hepatoblastoma HepG2 cell lineJun Zhang, Chao Cheng, Chuang-Long He, et al.Cancer Investigation|June 24, 2008
Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?Shou-Ching TangCancer Investigation|June 24, 2008
High levels of granzyme B expression in invasive cervical carcinoma correlates to poor response to treatmentValeska B Guzman, Ismael D C G Silva, Sylvia M F Brenna, et al.Cancer Investigation|September 14, 2007
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma: a dose-finding studyM Reni, S Cereda, E Bonetto, et al.Cancer Investigation|September 14, 2007
Urticaria and angioedema in renal cell cancer patients treated with IL-2Theodore F Logan, Giovanni Strippoli, Macy I LevineCancer Investigation|September 21, 2007
A Phase II trial of oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX4) as first-line chemotherapy in advanced colorectal cancer: a China single-center experienceNong Xu, Wei-Jia Fang, Xiao-Chen Zhang, et al.Cancer Investigation|September 21, 2007
Effect of adenosine on the growth of human T-lymphocyte leukemia cell line MOLT-4Denisa Streitová, Lenka Weiterová, Michal Hofer, et al.Pageof 296